Axsome Therapeutics Inc Dividends
The next dividend date for Axsome Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Axsome Therapeutics Inc (AXSM)
More About Axsome Therapeutics Inc
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT1A agonist indicated for the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea; and Symbravo (MoSEIC meloxicam rizatriptan), or AXS-07, a rapidly absorbed, multi-mechanistic, selective COX-2 inhibitor, and 5-HT1B/1D agonist indicated for the acute treatment of migraine with or without aura. It also develops AXS-05 (dextromethorphan-bupropion), an investigational N-methyl-D-aspartate receptor antagonist, which has completed Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-12 (reboxetine), a highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator, which has completed Phase III trial to treat narcolepsy; AXS-14 (esreboxetine), a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, which is in Phase III trial for treating attention deficit hyperactivity, major depressive, binge eating, and excessive sleepiness associated with shift work disorder. The company has a research collaboration agreement with Duke University for evaluating AXS-05 in a Phase 2 clinical trial in smoking cessation. Axsome Therapeutics, Inc. was incorporated in 2012 and is based in New York, New York.
Owning Axsome Therapeutics Inc Stock on the Dividend Date
If you own Axsome Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Axsome Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Axsome Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Axsome Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Axsome Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning Axsome Therapeutics Inc Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in Axsome Therapeutics Inc stock price from the dividend is already baked into Axsome Therapeutics Inc option prices.
That means the prices of call options that overlap the Axsome Therapeutics Inc ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the Axsome Therapeutics Inc ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of Axsome Therapeutics Inc call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Axsome Therapeutics Inc put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More Axsome Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about Axsome Therapeutics Inc dividends or anything else related to the stock market.